Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES Location: Virus and Prion Research 
Unit 
2011 Annual Report 
1a.Objectives (from AD-416) Obj. 1. Assess the cross species 
transmissibility of transmissible spongiform encephalopathies (TSEs) in 
livestock and wildlife. Obj. 2. Investigate the pathobiology of TSEs in natural 
and secondary hosts. Obj. 3. Investigate pathogenesis and ante mortem detection 
of bovine spongiform encephalopathy (BSE). Obj. 4. Develop a method to detect 
central nervous system (CNS) tissue contamination on carcasses. Obj. 5. Discover 
effective methods to inactivate TSE agents in agricultural settings. 
1b.Approach (from AD-416) Studies are focused on the four animal 
Transmissible Spongiform Encephalopathy (TSE) agents found in the United States: 
bovine spongiform encephalopathy (BSE); scrapie of sheep and goats; chronic 
wasting disease (CWD) of deer, elk, and moose; and transmissible mink 
encephalopathy (TME). These agents will be tested for cross-species 
transmissibility into various livestock and cervid species using both oral and 
intracerebral inoculation. Sites of accumulation, routes of infection, methods 
of isolate differentiation, and in the case of BSE, genetics of susceptibility 
and ante-mortem diagnostics, will be investigated. Existing technology developed 
at the National Animal Disease Center and those used in the meat packing 
industry for the detection of fecal contamination on carcasses will be adapted 
to detect CNS tissue contamination on carcasses. Methods of TSE inactivation 
will be evaluated for efficacy in agricultural settings. 
3.Progress Report This is the final report for project 3625-32000-086-00D, 
terminated in September 2011 and replaced by 3625-32000-103-00D. The project 
plan involved 5 objectives. 
In Objective 1, Assess cross-species transmissibility of transmissible 
spongiform encephalopathies (TSEs) in livestock and wildlife, numerous 
experiments assessing the susceptibility of various TSEs in different host 
species were conducted. Most notable is deer inoculated with scrapie, which 
exhibits similarities to chronic wasting disease (CWD) in deer suggestive of 
sheep scrapie as an origin of CWD. 
In Objective 2, Investigate the pathobiology of TSEs in natural and 
secondary hosts, deer were inoculated with CWD-infected blood. Several animals 
developed clinical signs, a result consistent with CWD infectivity in blood. 
Also, biochemical strain typing commonly used for rodent models of TSE was 
investigated to assess the importance of genetic variability in natural hosts 
and how to apply these methods to natural hosts. 
Objective 3, Investigate pathogenesis and antemortem detection of bovine 
spongiform encephalopathy (BSE), involves several different research areas. Our 
results in genetic susceptibility of BSE support the now widely accepted 
conclusion that atypical BSE is a spontaneous TSE in cattle. This has important 
implications for the ruminant feed ban, food safety, and our understanding of 
the origins of BSE. Also as part of Obj. 3, we identified the first recognized 
case of genetic BSE where a natural case of BSE was identified in an animal 
containing a polymorphism analogous to a human polymorphism that causes a 
genetic TSE. Bovine spongiform encephalopathy has long been believed to only be 
a feed-borne disease. Together, our results show for the first time the presence 
of three different etiologies for BSE as are known to occur in humans. As part 
of our investigation, classical, and atypical BSE isolates were inoculated into 
cattle. Upon completion, this work will represent the first thorough comparison 
of domestic and international BSE isolates, including both classical and 
atypical BSE. An antemortem diagnostic technique based upon retinal function was 
developed and is routinely applied to experimental animals on site. This 
technique detects a TSE before the onset of clinical signs. Work is ongoing to 
increase the number of animals containing the E211K polymorphism, a potential 
cause of genetic BSE; this will provide the only means by which to prove the 
novel allele may cause BSE. The unusual E211K BSE material has also been 
successfully amplified in one of these animals. 
Objective 4, Develop a method to detect CNS tissue contamination on 
carcasses, resulted in a successful method that may be applied through 
adaptation of existing technology currently used to detect fecal contamination 
on carcasses. 
In Objective 5, Determine effective methods to inactivate TSE agents in 
agricultural settings, compounds applicable to agricultural settings were 
evaluated; the results are being prepared for publication. As part of this 
objective, a natural host model for assessing inactivation was developed. 
Despite experimental success the model is not suitable due to incubation time. 
4.Accomplishments 1. Deer inoculated with domestic isolates of sheep 
scrapie. Scrapie-affected deer exhibit 2 different patterns of disease 
associated prion protein. In some regions of the brain the pattern is much like 
that observed for scrapie, while in others it is more like chronic wasting 
disease (CWD), the transmissible spongiform encephalopathy typically associated 
with deer. This work conducted by ARS scientists at the National Animal Disease 
Center, Ames, IA suggests that an interspecies transmission of sheep scrapie to 
deer may have been the origin of CWD. This is important for husbandry practices 
with both captive deer, elk and sheep for farmers and ranchers attempting to 
keep their herds and flocks free of CWD and scrapie. 
2. Demonstrated transmissibility of K211 BSE, a rare genetic form of bovine 
spongiform encephalopathy (BSE), to cattle. Cattle containing the rare K211 PRNP 
gene have been produced in-house and used in this study conducted by ARS 
scientists at the National Animal Disease Center, Ames, IA. These animals have 
been inoculated with both K211 BSE and classical BSE. The K211 BSE is 
transmissible and progresses far more rapidly in K211 cattle than does classical 
BSE. Because of their genetic susceptibility to BSE, K211 PRNP cattle have a 
very rapid incubation time and may be more susceptible to TSEs, which are two 
characteristics that make them highly desirable for future studies of antemortem 
diagnostics and residual infectivity or risk materials after decontamination. 
The possibility remains that K211 BSE transmitted to conventional cattle will 
result in a disease phenotype similar to classical BSE. If this turns out to be 
true, then it will be very important in that it suggests a very rare genetic 
form of BSE could have been the original source of brain material responsible 
for the U.K. BSE epidemic. Current human and animal feed bans regarding 
specified risk materials from cattle protect humans and animals from a 
recurrence of such an epidemic. 
Review Publications Hamir, A.N., Greenlee, J.J., Stanton, T.B., Smith, 
J.D., Doucette, S., Kunkle, R.A., Stasko, J.A., Richt, J.A., Kehrli, Jr., M.E. 
2011. Experimental inoculation of raccoons (Procyon lotor) with Spiroplasma 
mirum and transmissible mink encephalopathy (TME). Canadian Journal of 
Veterinary Research. 75(1):18–24. 
 Hamir, A.N., Greenlee, J.J., Nicholson, E.M., Kunkle, R.A., Richt, J.A., 
Miller, J.M., Hall, M. 2011. Experimental transmission of chronic wasting 
disease (CWD) from elk and white-tailed deer to fallow deer by intracerebral 
route: final report. Canadian Journal of Veterinary Research. 75(2):152-156. 
Smith, J.D., Hamir, A.N., Greenlee, J.J. 2011. Cartilaginous metaplasia in 
the sclera of Suffolk sheep. Veterinary Pathology. 48(4):827-829. 
Loiacono, C.M., Beckwith, N., Kunkle, R.A., Orcutt, D., Hall, S.M. 2010. 
Detection of PrPSc in formalin-fixed, paraffin embedded tissue by Western blot 
differentiates classical scrapie, Nor98 scrapie, and bovine spongiform 
encephalopathy. Journal of Veterinary Diagnostic Investigation. 22(5):684-689. 
Hamir, A.N., Kehrli, Jr., M.E., Kunkle, R.A., Greenlee, J.J., Nicholson, 
E.M., Richt, J.A., Miller, J.M., Cutlip, R.C. 2011. Experimental interspecies 
transmission studies of the transmissible spongiform encephalopathies to cattle: 
comparison to bovine spongiform encephalopathy in cattle. Journal of Veterinary 
Diagnostic Investigation. 23(3):407-420. 
Nicholson, E.M. 2011. Enrichment of PrPSc in formalin-fixed, 
paraffin-embedded tissues prior to analysis by Western blot. Journal of 
Veterinary Diagnostic Investigation. 23(4):790-792. 
Atypical H-Type Bovine Spongiform Encephalopathy in a Cow Born after the 
Reinforced Feed-Ban on Meat-and-Bone-Meal 
Claudia Guldimann1, Michaela Gsponer1, Cord Drögemüller2, Anna Oevermann1 
and Torsten Seuberlich1,*
+ Author Affiliations
1NeuroCentre, National and OIE Reference Laboratory for BSE and Scrapie 
2Institute of Genetics, Vetsuisse Faculty, University of Berne, Berne, 
Switzerland 
ABSTRACT 
The significance of atypical bovine spongiform encephalopathies (BSE) in 
cattle for controlling the BSE epidemic is poorly understood. Here we report a 
case of atypical H-type BSE born after the implementation of the reinforced 
feed-ban in Europe. This supports an etiology of H-type BSE unrelated to that of 
classical BSE. 
 FOOTNOTES ↵* Corresponding author. Mailing address: NeuroCentre, DCR-VPH, 
Bremgartenstrasse 109a, CH-3001 Berne, Switzerland. Phone: 41 31 631 2206. Fax: 
41 31 631 2538. E-mail: torsten.seuberlich@vetsuisse.unibe.ch Copyright © 2012, 
American Society for Microbiology. All Rights Reserved. 
 snip... 
In contrast, the animal described here was 6.5 years old, CNS specific 
neurological signs were not observed, and spongiform lesions as well as PrPd 
deposits in the brain were minimal. All this supports that it was in an early, 
preclinical stage of the disease. In this regard it is important to point out 
that these minimal lesions and PrPd deposits were found in the grey matter 
structures of the obex region of the medulla oblongata, the midbrain and the 
thalamus. These findings are essentially similar to those in preclinical C-type 
BSE (1,12,13,22) and support that sampling of the obex region in surveillance 
schemes implemented for C98 type BSE might be similarly suitable for detection 
of naturally occurring H-type BSE.
The main disease-control measure of C-type BSE is the ban on mammalian MBM 
in ruminant feed. This feed-ban was enforced in Switzerland and the European 
Union in the early 1990s and considerably reduced the number of newly infected 
cattle. However, the recycling of the C-type BSE agent in the cattle population 
was not blocked until the MBM feed-ban was reinforced in 2001, now excluding the 
use of animal proteins in feed of all farmed animals (10). 
It remains unknown, whether H-type BSE similarly transmits orally in the 
cattle population with MBM as a vehicle or not. If oral transmission occurs and 
is the sole etiology, the reinforced MBM feed-ban should be an appropriate 
measure to prevent the spread of H-type BSE also and no cases should be born 
after its implementation, i.e., after 2001 in Switzerland and Germany. 
To our knowledge, this is the first report of an H-type BSE affected animal 
being born after the reinforced MBM feed-ban in the respective country. 
Therefore, this case provides further evidence that the etiology of H-type BSE 
may be unrelated to the ingestion of prion contaminated meat-and-bone meal. 
Taken together, this supports the widely expressed postulate that H-type BSE 
originates from a spontaneous misfolding of cellular PrP with a pathophysiology 
similar to sporadic Creutzfeld-Jakob disease in humans (7,20).
Alternatively, other yet unknown routes of transmission or genetic 
determinants must be considered. This said, H-type BSE might persist after 
eradication of C-type BSE. What are the implications of this scenario? Studies 
in mice provided experimental evidence that H-type BSE may shift its disease 
phenotype to that of C-type BSE (3) upon transmission. It has therefore been 
hypothesized that the C-type BSE epidemic originated from spontaneously 
occurring H-type BSE cases. If this was the case there would be a constant risk 
that C-type BSE re-emerges in the cattle population once the feed-ban is 
discontinued. Consequently, some measures of disease control would need to be 
maintained indefinitely. Since the standards for the determination of a 
countries’ BSE risk status currently do not differentiate between BSE subtypes 
(28), BSE risk assessments will certainly need to take such considerations into 
account. This highlights the need for continuing research into the relationship 
between classical and atypical BSE variants to provide the scientific basis for 
future disease surveillance and control policies. 
re-Atypical H-Type Bovine Spongiform Encephalopathy in a Cow Born after the 
Reinforced Feed-Ban on Meat-and-Bone-Meal 
please note, one decade (10 years), post USA mad cow partial and voluntary 
mad cow feed ban of August 4, 1997, the USA was still feeding cows to cows, with 
some 10,000,000 pounds of banned blood laced meat and bone meal fed out into 
commerce in 2007. 2006 was a banner year for mad cow protein into commerce as 
well. 
please see banned mad cow feed in commerce USA 1997 to 2007 ; 
2007 
10,000,000+ LBS. of PROHIBITED BANNED MAD COW FEED I.E. BLOOD LACED MBM IN 
COMMERCE USA 2007 
Date: March 21, 2007 at 2:27 pm PST 
RECALLS AND FIELD CORRECTIONS: VETERINARY MEDICINES -- CLASS II 
PRODUCT 
Bulk cattle feed made with recalled Darling's 85% Blood Meal, Flash Dried, 
Recall # V-024-2007 
CODE 
Cattle feed delivered between 01/12/2007 and 01/26/2007 
RECALLING FIRM/MANUFACTURER 
Pfeiffer, Arno, Inc, Greenbush, WI. by conversation on February 5, 2007. 
Firm initiated recall is ongoing. 
REASON 
Blood meal used to make cattle feed was recalled because it was cross- 
contaminated with prohibited bovine meat and bone meal that had been 
manufactured on common equipment and labeling did not bear cautionary BSE 
statement. 
VOLUME OF PRODUCT IN COMMERCE 
42,090 lbs. 
DISTRIBUTION 
WI 
___________________________________ 
PRODUCT 
Custom dairy premix products: 
MNM ALL PURPOSE Pellet, HILLSIDE/CDL Prot- Buffer Meal, LEE, M.-CLOSE UP PX 
Pellet, HIGH DESERT/ GHC LACT Meal, TATARKA, M CUST PROT Meal, SUNRIDGE/CDL 
PROTEIN Blend, LOURENZO, K PVM DAIRY Meal, DOUBLE B DAIRY/GHC LAC Mineral, WEST 
PIONT/GHC CLOSEUP Mineral, WEST POINT/GHC LACT Meal, JENKS, J/COMPASS PROTEIN 
Meal, COPPINI - 8# SPECIAL DAIRY Mix, GULICK, L-LACT Meal (Bulk), TRIPLE J - 
PROTEIN/LACTATION, ROCK CREEK/GHC MILK Mineral, BETTENCOURT/GHC S.SIDE MK-MN, 
BETTENCOURT #1/GHC MILK MINR, V&C DAIRY/GHC LACT Meal, VEENSTRA, F/GHC LACT 
Meal, SMUTNY, A- BYPASS ML W/SMARTA, Recall # V-025-2007 
CODE 
The firm does not utilize a code - only shipping documentation with 
commodity and weights identified. 
RECALLING FIRM/MANUFACTURER 
Rangen, Inc, Buhl, ID, by letters on February 13 and 14, 2007. Firm 
initiated recall is complete. 
REASON 
Products manufactured from bulk feed containing blood meal that was cross 
contaminated with prohibited meat and bone meal and the labeling did not bear 
cautionary BSE statement. 
VOLUME OF PRODUCT IN COMMERCE 
9,997,976 lbs. 
DISTRIBUTION 
ID and NV 
END OF ENFORCEMENT REPORT FOR MARCH 21, 2007 
please see 2006 and more here ; 
Saturday, August 4, 2012 
Final Feed Investigation Summary - California BSE Case - July 2012 
Wednesday, May 30, 2012
PO-028: Oral transmission of L-type bovine spongiform encephalopathy 
(L-BSE) in primate model Microcebus murinus 
Wednesday, May 2, 2012 
ARS FLIP FLOPS ON SRM REMOVAL FOR ATYPICAL L-TYPE BASE BSE RISK HUMAN AND 
ANIMAL HEALTH 
Wednesday, July 28, 2010 
re-Freedom of Information Act Project Number 3625-32000-086-05, Study of 
Atypical BSE UPDATE July 28, 2010 
Sent: Wednesday, July 28, 2010 11:42 AM
Subject: re-Freedom of Information Act Project Number 3625-32000-086-05, 
Study of Atypical BSE UPDATE 
Greetings again Ms Williams et al at FOIA USDA, 
Thank You again for your kind reply on this important information. However, 
I am concerned that you may not be aware of new transmission studies. You (USDA 
et al) state Ma'am ; 
 ================================================ 
The SCA with Italy was mainly to confirm our respective country’s 
diagnostic tests would detect the various atypical BSE cases as seen in each 
country), in the meantime, the Italians have published their transmissibility 
and pathogenesis work on their BASE cases in the following article:
Lombardi G, Casalone C, A DA, Gelmetti D, Torcoli G, Barbieri I, Corona C, 
Fasoli E, Farinazzo A, Fiorini M, Gelati M, Iulini B, Tagliavini F, Ferrari S, 
Caramelli M, Monaco S, Capucci L, Zanusso G (2008) Intraspecies transmission of 
BASE induces clinical dullness and amyotrophic changes. PLoS Pathog 
4:e1000075
The above mentioned paper concludes, “In all experimentally infected 
animals, no PrP**TSE was detected in peripheral tissues, including cervical and 
mesenteric lymph nodes, spleen, thymus, liver, lung, peripheral nerves and 
forelimb and limb muscles, either by standard Western blot analysis or following 
phosphotungstic acid precipitation.“
It is not necessary to change SRM removal due to any different tissue 
infectivity distribution between classical BSE and atypical BSE. At this time, 
there is no scientific evidence to suggest a need for expanding the list of 
tissues included in the Specified Risk Material (SRM) ban as a result of 
published studies on atypical BSE. 
snip... 
Moreover, in the paper by Buschmann A, Groschup MH (2005,) Highly bovine 
spongiform encephalopathy-sensitive transgenic mice confirm the essential 
restriction of infectivity to the nervous system in clinically diseased cattle. 
J Infect Dis 192:934-942; the authors, when speaking about the classical BSE 
food-borne epidemic in Europe, concluded their “results provide further 
indication that the pathogenesis of BSE in cattle is fundamentally different 
from that in sheep and mice, due to an exclusive intraneuronal spread of 
infectivity from the gut to the central nervous system.” 
end... 
================================================ 
Again, in my opinion, the USDA is cherry picking the science they want to 
use, and in doing so, I believe they are putting human lives at risk. 
I disagree for the following reasons. New studies indeed show that ; 
July 10, 2010 
see full text ; 
Wednesday, July 28, 2010 
re-Freedom of Information Act Project Number 3625-32000-086-05, Study of 
Atypical BSE UPDATE July 28, 2010 
USDA TRIPLE BSE MAD COW FIREWALL, SRM, FEED, AND SURVEILLANCE 
 2012 
***Also, a link is suspected between atypical BSE and some apparently 
sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases 
constitute an unforeseen first threat that could sharply modify the European 
approach to prion diseases. 
Second threat 
snip... 
MAD COW USDA ATYPICAL L-TYPE BASE BSE, the rest of the story... 
***Oral Transmission of L-type Bovine Spongiform Encephalopathy in Primate 
Model 
***Infectivity in skeletal muscle of BASE-infected cattle 
***feedstuffs- It also suggests a similar cause or source for atypical BSE 
in these countries. 
***Also, a link is suspected between atypical BSE and some apparently 
sporadic cases of Creutzfeldt-Jakob disease in humans. 
The present study demonstrated successful intraspecies transmission of 
H-type BSE to cattle and the distribution and immunolabeling patterns of PrPSc 
in the brain of the H-type BSE-challenged cattle. TSE agent virulence can be 
minimally defined by oral transmission of different TSE agents (C-type, L-type, 
and H-type BSE agents) [59]. Oral transmission studies with H-type BSEinfected 
cattle have been initiated and are underway to provide information regarding the 
extent of similarity in the immunohistochemical and molecular features before 
and after transmission. 
In addition, the present data will support risk assessments in some 
peripheral tissues derived from cattle affected with H-type BSE. 
Friday, May 11, 2012
Experimental H-type bovine spongiform encephalopathy characterized by 
plaques and glial- and stellate-type prion protein deposits 
***support risk assessments in some peripheral tissues derived from cattle 
affected with H-type BSE 
Thursday, June 21, 2012 
Clinical and Pathologic Features of H-Type Bovine Spongiform Encephalopathy 
Associated with E211K Prion Protein Polymorphism 
Justin J. Greenlee1*, Jodi D. Smith1, M. Heather West Greenlee2, Eric M. 
Nicholson1 
1 National Animal Disease Center, United States Department of Agriculture, 
Agricultural Research Service, Ames, Iowa, United States of America, 2 Iowa 
State University, Ames, Iowa, United States of America 
Abstract 
The majority of bovine spongiform encephalopathy (BSE) cases have been 
ascribed to the classical form of the disease. Htype and L-type BSE cases have 
atypical molecular profiles compared to classical BSE and are thought to arise 
spontaneously. However, one case of H-type BSE was associated with a heritable 
E211K mutation in the prion protein gene. The purpose of this study was to 
describe transmission of this unique isolate of H-type BSE when inoculated into 
a calf of the same genotype by the intracranial route. Electroretinograms were 
used to demonstrate preclinical deficits in retinal function, and optical 
coherence tomography was used to demonstrate an antemortem decrease in retinal 
thickness. The calf rapidly progressed to clinical disease (9.4 months) and was 
necropsied. Widespread distribution of abnormal prion protein was demonstrated 
within neural tissues by western blot and immunohistochemistry. While this 
isolate is categorized as BSE-H due to a higher molecular mass of the 
unglycosylated PrPSc isoform, a strong labeling of all 3 PrPSc bands with 
monoclonal antibodies 6H4 and P4, and a second unglycosylated band at 
approximately 14 kDa when developed with antibodies that bind in the C-terminal 
region, it is unique from other described cases of BSE-H because of an 
additional band 23 kDa demonstrated on western blots of the cerebellum. This 
work demonstrates that this isolate is transmissible, has a BSE-H phenotype when 
transmitted to cattle with the K211 polymorphism, and has molecular features 
that distinguish it from other cases of BSE-H described in the literature. 
snip... 
Most significantly it must be determined if the molecular phenotype of this 
cattle TSE remains stable when transmitted to cattle without the E211K 
polymorphism as several other isolates of atypical BSE have been shown to adopt 
a molecular profile consistent with classical BSE after passage in transgenic 
mice expressing bovine PrPC [40] or multiple passages in wild type mice [23]. 
Results of ongoing studies, namely passage of the E211K Htype isolate into 
wild-type cattle, will lend further insight into what role, if any, genetic and 
sporadic forms of BSE may have played in the origins of classical BSE. Atypical 
cases presumably of spontaneous or, in the case of E211K BSE-H, genetic origins 
highlight that it may not be possible to eradicate BSE entirely and that it 
would be hazardous to remove disease control measures such as prohibiting the 
feeding of meat and bone meal to ruminants. 
P.4.23 
Transmission of atypical BSE in humanized mouse models 
Liuting Qing1, Wenquan Zou1, Cristina Casalone2, Martin Groschup3, Miroslaw 
Polak4, Maria Caramelli2, Pierluigi Gambetti1, Juergen Richt5, Qingzhong Kong1 
1Case Western Reserve University, USA; 2Instituto Zooprofilattico Sperimentale, 
Italy; 3Friedrich-Loeffler-Institut, Germany; 4National Veterinary Research 
Institute, Poland; 5Kansas State University (Previously at USDA National Animal 
Disease Center), USA 
Background: Classical BSE is a world-wide prion disease in cattle, and the 
classical BSE strain (BSE-C) has led to over 200 cases of clinical human 
infection (variant CJD). Atypical BSE cases have been discovered in three 
continents since 2004; they include the L-type (also named BASE), the H-type, 
and the first reported case of naturally occurring BSE with mutated bovine PRNP 
(termed BSE-M). The public health risks posed by atypical BSE were largely 
undefined. 
Objectives: To investigate these atypical BSE types in terms of their 
transmissibility and phenotypes in humanized mice. Methods: Transgenic mice 
expressing human PrP were inoculated with several classical (C-type) and 
atypical (L-, H-, or Mtype) BSE isolates, and the transmission rate, incubation 
time, characteristics and distribution of PrPSc, symptoms, and histopathology 
were or will be examined and compared. 
Results: Sixty percent of BASE-inoculated humanized mice became infected 
with minimal spongiosis and an average incubation time of 20-22 months, whereas 
only one of the C-type BSE-inoculated mice developed prion disease after more 
than 2 years. Protease-resistant PrPSc in BASE-infected humanized Tg mouse 
brains was biochemically different from bovine BASE or sCJD. PrPSc was also 
detected in the spleen of 22% of BASE-infected humanized mice, but not in those 
infected with sCJD. Secondary transmission of BASE in the humanized mice led to 
a small reduction in incubation time.*** The atypical BSE-H strain is also 
transmissible with distinct phenotypes in the humanized mice, but no BSE-M 
transmission has been observed so far. 
Discussion: Our results demonstrate that BASE is more virulent than 
classical BSE, has a lymphotropic phenotype, and displays a modest transmission 
barrier in our humanized mice. BSE-H is also transmissible in our humanized Tg 
mice. The possibility of more than two atypical BSE strains will be discussed. 
Supported by NINDS NS052319, NIA AG14359, and NIH AI 77774. 
P26 TRANSMISSION OF ATYPICAL BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) IN 
HUMANIZED MOUSE MODELS 
Liuting Qing1, Fusong Chen1, Michael Payne1, Wenquan Zou1, Cristina 
Casalone2, Martin Groschup3, Miroslaw Polak4, Maria Caramelli2, Pierluigi 
Gambetti1, Juergen Richt5*, and Qingzhong Kong1 1Department of Pathology, Case 
Western Reserve University, Cleveland, OH 44106, USA; 2CEA, Istituto 
Zooprofilattico Sperimentale, Italy; 3Friedrich-Loeffler-Institut, Germany; 
4National Veterinary Research Institute, Poland; 5Kansas State University, 
Diagnostic Medicine/Pathobiology Department, Manhattan, KS 66506, USA. *Previous 
address: USDA National Animal Disease Center, Ames, IA 50010, USA 
Classical BSE is a world-wide prion disease in cattle, and the classical 
BSE strain (BSE-C) has led to over 200 cases of clinical human infection 
(variant CJD). Two atypical BSE strains, BSE-L (also named BASE) and BSE-H, have 
been discovered in three continents since 2004. The first case of naturally 
occurring BSE with mutated bovine PrP gene (termed BSE-M) was also found in 2006 
in the USA. The transmissibility and phenotypes of these atypical BSE 
strains/isolates in humans were unknown. We have inoculated humanized transgenic 
mice with classical and atypical BSE strains (BSE-C, BSE-L, BSE-H) and the BSE-M 
isolate. We have found that the atypical BSE-L strain is much more virulent than 
the classical BSE-C.*** The atypical BSE-H strain is also transmissible in the 
humanized transgenic mice with distinct phenotype, but no transmission has been 
observed for the BSE-M isolate so far. 
III International Symposium on THE NEW PRION BIOLOGY: BASIC SCIENCE, 
DIAGNOSIS AND THERAPY 2 - 4 APRIL 2009, VENEZIA (ITALY) 
I ask Professor Kong ;
Thursday, December 04, 2008 3:37 PM Subject: RE: re--Chronic Wating Disease 
(CWD) and Bovine Spongiform Encephalopathies (BSE): Public Health Risk 
Assessment
''IS the h-BSE more virulent than typical BSE as well, or the same as cBSE, 
or less virulent than cBSE? just curious.....''
Professor Kong reply ;
.....snip 
''As to the H-BSE, we do not have sufficient data to say one way or 
another, but we have found that H-BSE can infect humans. I hope we could publish 
these data once the study is complete. Thanks for your interest.'' 
Best regards, 
Qingzhong Kong, PhD Associate Professor Department of Pathology Case 
Western Reserve University Cleveland, OH 44106 USA 
END...TSS 
Thursday, December 04, 2008 2:37 PM
"we have found that H-BSE can infect humans."
personal communication with Professor Kong. ...TSS 
BSE-H is also transmissible in our humanized Tg mice. 
The possibility of more than two atypical BSE strains will be discussed. 
Supported by NINDS NS052319, NIA AG14359, and NIH AI 77774. 
let's take a closer look at this new prionpathy or prionopathy, and then 
let's look at the g-h-BSEalabama mad cow.
This new prionopathy in humans? the genetic makeup is IDENTICAL to the 
g-h-BSEalabama mad cow, the only _documented_ mad cow in the world to date like 
this, ......wait, it get's better. this new prionpathy is killing young and old 
humans, with LONG DURATION from onset of symptoms to death, and the symptoms are 
very similar to nvCJD victims, OH, and the plaques are very similar in some 
cases too, bbbut, it's not related to the g-h-BSEalabama cow, WAIT NOW, it gets 
even better, the new human prionpathy that they claim is a genetic TSE, has no 
relation to any gene mutation in that family. daaa, ya think it could be related 
to that mad cow with the same genetic make-up ??? there were literally tons and 
tons of banned mad cow protein in Alabama in commerce, and none of it 
transmitted to cows, and the cows to humans there from ??? r i g h t $$$
ALABAMA MAD COW g-h-BSEalabama
In this study, we identified a novel mutation in the bovine prion protein 
gene (Prnp), called E211K, of a confirmed BSE positive cow from Alabama, United 
States of America. This mutation is identical to the E200K pathogenic mutation 
found in humans with a genetic form of CJD. This finding represents the first 
report of a confirmed case of BSE with a potential pathogenic mutation within 
the bovine Prnp gene. We hypothesize that the bovine Prnp E211K mutation most 
likely has caused BSE in "the approximately 10-year-old cow" carrying the E221K 
mutation. 
her healthy calf also carried the mutation (J. A. Richt and S. M. Hall PLoS 
Pathog. 4, e1000156; 2008).
This raises the possibility that the disease could occasionally be genetic 
in origin. Indeed, the report of the UK BSE Inquiry in 2000 suggested that the 
UK epidemic had most likely originated from such a mutation and argued against 
the scrapierelated assumption. Such rare potential pathogenic PRNP mutations 
could occur in countries at present considered to be free of BSE, such as 
Australia and New Zealand. So it is important to maintain strict surveillance 
for BSE in cattle, with rigorous enforcement of the ruminant feed ban (many 
countries still feed ruminant proteins to pigs). Removal of specified risk 
material, such as brain and spinal cord, from cattle at slaughter prevents 
infected material from entering the human food chain. Routine genetic screening 
of cattle for PRNP mutations, which is now available, could provide additional 
data on the risk to the public. Because the point mutation identified in the 
Alabama animals is identical to that responsible for the commonest type of 
familial (genetic) CJD in humans, it is possible that the resulting infective 
prion protein might cross the bovine–human species barrier more easily. Patients 
with vCJD continue to be identified. The fact that this is happening less often 
should not lead to relaxation of the controls necessary to prevent future 
outbreaks.
Malcolm A. Ferguson-Smith Cambridge University Department of Veterinary 
Medicine, Madingley Road, Cambridge CB3 0ES, UK e-mail: maf12@cam.ac.uk Jürgen 
A. Richt College of Veterinary Medicine, Kansas State University, K224B Mosier 
Hall, Manhattan, Kansas 66506-5601, USA
NATURE|Vol 457|26 February 2009
Saturday, August 14, 2010
BSE Case Associated with Prion Protein Gene Mutation (g-h-BSEalabama) and 
VPSPr PRIONPATHY
(see mad cow feed in COMMERCE IN ALABAMA...TSS)
P.9.21
Molecular characterization of BSE in Canada
Jianmin Yang1, Sandor Dudas2, Catherine Graham2, Markus Czub3, Tim 
McAllister1, Stefanie Czub1 1Agriculture and Agri-Food Canada Research Centre, 
Canada; 2National and OIE BSE Reference Laboratory, Canada; 3University of 
Calgary, Canada
Background: Three BSE types (classical and two atypical) have been 
identified on the basis of molecular characteristics of the misfolded protein 
associated with the disease. To date, each of these three types have been 
detected in Canadian cattle.
Objectives: This study was conducted to further characterize the 16 
Canadian BSE cases based on the biochemical properties of there associated 
PrPres. Methods: Immuno-reactivity, molecular weight, glycoform profiles and 
relative proteinase K sensitivity of the PrPres from each of the 16 confirmed 
Canadian BSE cases was determined using modified Western blot analysis.
Results: Fourteen of the 16 Canadian BSE cases were C type, 1 was H type 
and 1 was L type. The Canadian H and L-type BSE cases exhibited size shifts and 
changes in glycosylation similar to other atypical BSE cases. PK digestion under 
mild and stringent conditions revealed a reduced protease resistance of the 
atypical cases compared to the C-type cases. N terminal- specific antibodies 
bound to PrPres from H type but not from C or L type. The C-terminal-specific 
antibodies resulted in a shift in the glycoform profile and detected a fourth 
band in the Canadian H-type BSE.
Discussion: The C, L and H type BSE cases in Canada exhibit molecular 
characteristics similar to those described for classical and atypical BSE cases 
from Europe and Japan. This supports the theory that the importation of BSE 
contaminated feedstuff is the source of C-type BSE in Canada.
*** It also suggests a similar cause or source for atypical BSE in these 
countries.
Saturday, May 26, 2012 
Are USDA assurances on mad cow case 'gross oversimplification'? 
SNIP... 
What irks many scientists is the USDA’s April 25 statement that the rare 
disease is “not generally associated with an animal consuming infected feed.” 
The USDA’s conclusion is a “gross oversimplification,” said Dr. Paul Brown, 
one of the world’s experts on this type of disease who retired recently from the 
National Institutes of Health. "(The agency) has no foundation on which to base 
that statement.” 
“We can’t say it’s not feed related,” agreed Dr. Linda Detwiler, an 
official with the USDA during the Clinton Administration now at Mississippi 
State. 
In the May 1 email to me, USDA’s Cole backed off a bit. “No one knows the 
origins of atypical cases of BSE,” she said 
The argument about feed is critical because if feed is the cause, not a 
spontaneous mutation, the California cow could be part of a larger outbreak. 
SNIP... 
2009 UPDATE ON ALABAMA AND TEXAS MAD COWS 2005 and 2006 
 in the url that follows, I have posted 
SRM breaches first, as late as 2011. 
then 
MAD COW FEED BAN BREACHES AND TONNAGES OF MAD COW FEED IN COMMERCE up until 
2007, when they ceased posting them. 
then, 
MAD COW SURVEILLANCE BREACHES. 
Friday, May 18, 2012 
Update from APHIS Regarding a Detection of Bovine Spongiform Encephalopathy 
(BSE) in the United States Friday May 18, 2012 
Wednesday, March 28, 2012 
VARIABLY PROTEASE-SENSITVE PRIONOPATHY IS TRANSMISSIBLE, price of prion 
poker goes up again $ 
OR-10 15:25 - 15:40 VARIABLY PROTEASE-SENSITIVE PRIONOPATHY IS 
TRANSMISSIBLE IN BANK VOLES Nonno 
OR-10: Variably protease-sensitive prionopathy is transmissible in bank 
voles
Romolo Nonno,1 Michele Di Bari,1 Laura Pirisinu,1 Claudia D’Agostino,1 
Stefano Marcon,1 Geraldina Riccardi,1 Gabriele Vaccari,1 Piero Parchi,2 Wenquan 
Zou,3 Pierluigi Gambetti,3 Umberto Agrimi1
1Istituto Superiore di Sanità; Rome, Italy; 2Dipartimento di Scienze 
Neurologiche, Università di Bologna; Bologna, Italy; 3Case Western Reserve 
University; Cleveland, OH USA
Background. Variably protease-sensitive prionopathy (VPSPr) is a recently 
described “sporadic”neurodegenerative disease involving prion protein 
aggregation, which has clinical similarities with non-Alzheimer dementias, such 
as fronto-temporal dementia. Currently, 30 cases of VPSPr have been reported in 
Europe and USA, of which 19 cases were homozygous for valine at codon 129 of the 
prion protein (VV), 8 were MV and 3 were MM. A distinctive feature of VPSPr is 
the electrophoretic pattern of PrPSc after digestion with proteinase K (PK). 
After PK-treatment, PrP from VPSPr forms a ladder-like electrophoretic pattern 
similar to that described in GSS cases. The clinical and pathological features 
of VPSPr raised the question of the correct classification of VPSPr among prion 
diseases or other forms of neurodegenerative disorders. Here we report 
preliminary data on the transmissibility and pathological features of VPSPr 
cases in bank voles. 
Materials and Methods. Seven VPSPr cases were inoculated in two genetic 
lines of bank voles, carrying either methionine or isoleucine at codon 109 of 
the prion protein (named BvM109 and BvI109, respectively). Among the VPSPr cases 
selected, 2 were VV at PrP codon 129, 3 were MV and 2 were MM. Clinical 
diagnosis in voles was confirmed by brain pathological assessment and western 
blot for PK-resistant PrPSc (PrPres) with mAbs SAF32, SAF84, 12B2 and 9A2.
Results. To date, 2 VPSPr cases (1 MV and 1 MM) gave positive transmission 
in BvM109. Overall, 3 voles were positive with survival time between 290 and 588 
d post inoculation (d.p.i.). All positive voles accumulated PrPres in the form 
of the typical PrP27–30, which was indistinguishable to that previously observed 
in BvM109 inoculated with sCJDMM1 cases. In BvI109, 3 VPSPr cases (2 VV and 1 
MM) showed positive transmission until now. Overall, 5 voles were positive with 
survival time between 281 and 596 d.p.i.. In contrast to what observed in 
BvM109, all BvI109 showed a GSS-like PrPSc electrophoretic pattern, 
characterized by low molecular weight PrPres. These PrPres fragments were 
positive with mAb 9A2 and 12B2, while being negative with SAF32 and SAF84, 
suggesting that they are cleaved at both the C-terminus and the N-terminus. 
Second passages are in progress from these first successful transmissions. 
Conclusions. Preliminary results from transmission studies in bank voles 
strongly support the notion that VPSPr is a transmissible prion disease. 
Interestingly, VPSPr undergoes divergent evolution in the two genetic lines of 
voles, with sCJD-like features in BvM109 and GSS-like properties in BvI109. The 
discovery of previously unrecognized prion diseases in both humans and animals 
(i.e., Nor98 in small ruminants) demonstrates that the range of prion diseases 
might be wider than expected and raises crucial questions about the epidemiology 
and strain properties of these new forms. We are investigating this latter issue 
by molecular and biological comparison of VPSPr, GSS and Nor98. 
Saturday, August 14, 2010
BSE Case Associated with Prion Protein Gene Mutation (g-h-BSEalabama) and 
VPSPr PRIONPATHY
(see mad cow feed in COMMERCE IN ALABAMA...TSS) 
There have been two molecular types of "atypical" BSE isolates described in 
the literature so far: 
(i) a type with a lower molecular mass of the unglycosylated isoform also 
called the L-type and 
(ii) a type with a higher molecular mass of the unglycosylated isoform, 
also called the H-type. 
The L-type has been found in cattle in Italy (10), Japan (11), Germany (12) 
and Belgium (13). 
So far, the H-type has been described in cattle from France (14), Germany 
(12) and the United States (15). 
The U.S. cases were animals born and raised in the U.S. (Texas, Alabama). 
Unusual cases of BSE are an 
unexpected finding since it was previously believed that BSE disease in 
cattle is caused by a single strain of 
infectious agent, which has been shown to be very consistent and uniform in 
appearance, even after 
transmission to other species. The reports of unusual phenotypes of BSE in 
cattle suggest that different PrPSc 
phenotypes exist in cattle with BSE. 
There are several hypotheses which can explain these findings: 
(i) there are variants of the BSE agent with different molecular features 
in cattle; 
(ii) cattle may have been infected by another source of an infectious prion 
agent (e.g. scrapie or CWD); or 
(iii) a rare sporadic or genetic form of TSE disease could exist in cattle 
as described for humans. 
DR. CLIFFORD: "Basically the IHC test, besides looking at location of the 
brain stem you're also doing a staining technique to identify abnormal prion 
proteins. In this case they had some staining, but the staining did not match up 
with what they would typically see in a BSE case. It didn't have the normal 
distribution it would see within the samples. So basically that's why the 
request for doing additional testing, and that's why we're sending it to 
Weybridge as well." 
DR. CLIFFORD: "There was some staining present. But it did not match a 
normal pattern, and we're taking through that to do additional tests in 
additional parts of the brain stem to try to see if we can find a normal 
staining pattern as well as sending that sample to Weybridge to run against 
their IHC." 
Atypical BSE
Atypical BSE, is a rare type of “madcow” disease that is not linked to the 
consumption of contaminated feed.The second (Texas) and third (Alabama) 
announced cases of U.S. BSE were atypical. ...
Subject: BSE, BOVINE - USA: ATYPICAL STRAIN Date: June 1, 2006 at 11:09 am 
PST BSE, BOVINE - USA: ATYPICAL STRAIN 
********************************** 
A ProMED-mail post
ProMED-mail, a program of the International Society for Infectious Diseases 
Date: 31 May 2006 From: Terry S. Singletary and Mary Marshall 
Source: Rapid City Journal [edited] 
 The 2 cases of bovine spongiform encephalopathy found in U.S. cattle over 
the past year came from a rare strain of BSE found largely in Europe that 
scientists are only beginning to identify, according to research by a French 
scientist. 
Researchers in France and Italy who presented their work at an 
international conference in London reported 2 rare strains of bovine spongiform 
encephalopathy that are harder to detect and affect mainly older cattle. 
Thierry Baron of the French Food Safety Agency presented research 
indicating that a 12-year-old Texas cow testing positive for BSE in June 2005, 
and the 10-year-old Alabama cow that tested positive in March [2006?], showed 
identical testing patterns to a small number of BSE cases in France, Sweden and 
Poland. 
Animal scientists are calling such strains "atypical" BSE, which is 
different from the "typical" BSE caused by cattle eating feed with ruminant 
offal contaminated with a BSE protein. 
They don't know whether the atypical strains are caused by something else 
or simply appear spontaneously in older, susceptible cattle. 
Art Davis, a U.S. Department of Agriculture (USDA) scientist for the Animal 
and Plant Health Inspection Service (APHIS) at the National Veterinary Services 
Laboratory in Ames, Iowa, said in his presentation Sunday at the London 
conference that the Texas and Alabama test results showed completely different 
prion patterns than the Washington state case discovered in December 2003. 
"The classical lesions were not there," Davis said of the cases. The 
Washington state cow originated in Alberta, Canada, near where several other BSE 
cases have been found. 
The "typical" BSE strain caused a mad cow disease epidemic in Great Britain 
beginning in the mid-1980s that killed 184 000 cattle and more than 100 people 
who contracted a human form of the disease caused by eating contaminated beef 
products. 
The scientific evidence shows that in almost all cattle cases, the fatal 
neurological disorder was contracted through contaminated meat and bone meal fed 
to the cow, typically at a young age. 
However, scientists finding atypical cases of BSE are beginning to question 
if there has been a change in the abnormal protein that causes BSE or if cattle 
might be susceptible to a sporadic BSE affecting older cattle. 
Danny Matthews, head of transmissible spongiform encephalopathies at 
England's Veterinary Laboratories Agency, said recent research on atypical cases 
of BSE raises questions over whether older cattle can sporadically get the 
disease or if there are more strains of BSE than previously understood. 
Scientists might also be facing something new, such as "son of BSE," he said. 
"We don't fully understand what atypical BSE means," Matthews said. "Is it 
spontaneous or another source causing it? Time will tell." 
Although the test patterns in the U.S. cases and atypical cases in Europe 
closely matched, Baron said there were no known links among any of the positive 
animals. The French Food Safety Agency sent a researcher to the United States to 
study the positive Texas case and compare its results to known cases in France 
that did not match the typical BSE positive tests. 
"You could place them side-by-side and not tell the difference," Baron 
said. 
Baron also raised the prospect that the disease could be sporadic in at 
least a small number of older cattle. He said, however, such a conclusion would 
be hard to determine because of the small number of cattle with this atypical 
strain globally. 
Dr. Sam Holland, South Dakota's state veterinarian, said there are many 
strains of BSE and varying degrees of infectiousness of the agent. 
"What if the scenario is there is an atypical prion out there that is much 
less infective, has a longer incubation period and has not been recognized as 
part of the Great Britain BSE experience identified in 1985 and '86?" Holland 
said. "There could be others out there that we haven't recognized yet." 
He said it is possible the atypical strains are not caused by contaminated 
feed and that it still makes sense to continue the ban on ruminant offal in 
cattle feed to prevent the spread of typical BSE and eventually to eliminate 
that disease. 
"Based on what we know about BSE, it makes good sense to -- number one -- 
keep some surveillance in place; number 2, watch what we import and restrict 
shipments and movements from places that have had those syndromes; and, number 
3, with what we know about BSE, it seems to be very prudent to keep our ruminant 
offal ban in place," Holland said. 
"At least for typical BSE's, it seems to be very effective. It's probably 
reasonable to continue the ruminant offal ban even after the last typical BSE 
case has been eliminated." 
Editor's note: DTN, a private company based in Omaha, Neb., provides 
information to agriculture, energy trading markets and other weather-sensitive 
industries. The Rapid City Journal received a copy of DTN's story and expanded 
on it. 
[Byline: Chris Clayton] 
-- Terry S. Singletary and Mary Marshall 
[An atypical form has been found in sheep with scrapie. Other countries 
have indicated an atypical form of BSE. It seems logical that the US would have 
an a atypical form as well. The case might even be made that new variant CJD is 
an atypical form of CJD. Clearly there is more to the TSE diseases than we fully 
comprehend. - Mod.TG] 
[see also: 2005 ---- Scrapie, atypical, ovine - Falkland Islands 
20051120.3371 2004 ---- Scrapie, atypical, sheep - UK and Ireland 20041210.3274 
Scrapie, atypical, sheep - UK (02) 20040409.0965 Scrapie, atypical, sheep - 
UK20040408.0952 BSE, atypical - France: OIE 20040201.0391 Scrapie, atypical, 
sheep - France: OIE 20040201.0390 BSE - France: distinct molecular phenotypes 
20040107.0076 2003 ---- Scrapie - Norway: new phenotype 20031117.2857 BSE - 
Japan (08): 9th case, lab findings 20031115.2838 BSE, atypical case - Italy: OIE 
20031022.2649 BSE - Italy: atypical, suspected 20031012.2576 BSE - Japan (06): 
atypical 20031009.2547 BSE - Japan (05): atypical 20031008.2526 BSE - Japan 
(04): atypical 20031007.2511 2002 ---- BSE? Sheep - USA (Vermont) 20020412.3937 
2000 ---- BSE? sheep - USA (Vermont) (06) 20000724.1223 BSE? sheep - USA 
(Vermont) 20000717.1184 1996 ---- CJD sporadic vs variant differences 
19960526.0990] ...............tg/pg/lm 
*##########################################################* 
************************************************************ 
END...TSS
2012
============================================== 
Saturday, August 4, 2012 
Final Feed Investigation Summary - California BSE Case - July 2012 
============================================= 
SUMMARY REPORT CALIFORNIA BOVINE SPONGIFORM ENCEPHALOPATHY CASE 
INVESTIGATION JULY 2012 
Summary Report BSE 2012
Executive Summary 
Saturday, August 4, 2012 
Update from APHIS Regarding Release of the Final Report on the BSE 
Epidemiological Investigation 
CENSORSHIP IS A TERRIBLE THING $$$ 
Canada has had a COVER-UP policy of mad cow disease since about the 17th 
case OR 18th case of mad cow disease. AFTER THAT, all FOIA request were ignored 
$$$ 
THIS proves there is indeed an epidemic of mad cow disease in North 
America, and it has been covered up for years and years, if not for decades, and 
it’s getting worse $$$ 
Thursday, February 10, 2011 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY REPORT UPDATE CANADA FEBRUARY 2011 
and how to hide mad cow disease in Canada Current as of: 2011-01-31 
Wednesday, August 11, 2010 
REPORT ON THE INVESTIGATION OF THE SIXTEENTH CASE OF BOVINE SPONGIFORM 
ENCEPHALOPATHY (BSE) IN CANADA 
Thursday, August 19, 2010 
REPORT ON THE INVESTIGATION OF THE SEVENTEENTH CASE OF BOVINE SPONGIFORM 
ENCEPHALOPATHY (BSE) IN CANADA 
Friday, March 4, 2011 
Alberta dairy cow found with mad cow disease 
Reasons for the New Regulation Order No. 23 (as well as amending Order No. 
149) of the State Committee for Veterinary Medicine name BSE as the reason for 
new import requirement. The legal title for Order No. 23 is "On Urgent Measures 
Aimed at Prevention and Elimination of BSE and Other Prion Infections in 
Cattle”. Neither Order explains how the threat of introduction of BSE can be 
addressed through the inspection of producers of all products of animal origin 
including fish, dairy products, poultry and pork. It is not clear what other 
concerns are addressed through the proposed inspections. Formal Notification of 
Trading Partners On August 3rd, Ukraine's Notification and Enquiry Point issued 
a legal Notification G/SPS/N/UKR/3/Rev.1 found on the Official WTO Website 
(Committee on Sanitary and Phytosanitary Measures) 
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES Location: Virus and Prion Research 
Unit 
2011 Annual Report 
1a.Objectives (from AD-416) Obj. 1. Assess the cross species 
transmissibility of transmissible spongiform encephalopathies (TSEs) in 
livestock and wildlife. Obj. 2. Investigate the pathobiology of TSEs in natural 
and secondary hosts. Obj. 3. Investigate pathogenesis and ante mortem detection 
of bovine spongiform encephalopathy (BSE). Obj. 4. Develop a method to detect 
central nervous system (CNS) tissue contamination on carcasses. Obj. 5. Discover 
effective methods to inactivate TSE agents in agricultural settings. 
1b.Approach (from AD-416) Studies are focused on the four animal 
Transmissible Spongiform Encephalopathy (TSE) agents found in the United States: 
bovine spongiform encephalopathy (BSE); scrapie of sheep and goats; chronic 
wasting disease (CWD) of deer, elk, and moose; and transmissible mink 
encephalopathy (TME). These agents will be tested for cross-species 
transmissibility into various livestock and cervid species using both oral and 
intracerebral inoculation. Sites of accumulation, routes of infection, methods 
of isolate differentiation, and in the case of BSE, genetics of susceptibility 
and ante-mortem diagnostics, will be investigated. Existing technology developed 
at the National Animal Disease Center and those used in the meat packing 
industry for the detection of fecal contamination on carcasses will be adapted 
to detect CNS tissue contamination on carcasses. Methods of TSE inactivation 
will be evaluated for efficacy in agricultural settings. 
3.Progress Report This is the final report for project 3625-32000-086-00D, 
terminated in September 2011 and replaced by 3625-32000-103-00D. The project 
plan involved 5 objectives. 
In Objective 1, Assess cross-species transmissibility of transmissible 
spongiform encephalopathies (TSEs) in livestock and wildlife, numerous 
experiments assessing the susceptibility of various TSEs in different host 
species were conducted. Most notable is deer inoculated with scrapie, which 
exhibits similarities to chronic wasting disease (CWD) in deer suggestive of 
sheep scrapie as an origin of CWD. 
In Objective 2, Investigate the pathobiology of TSEs in natural and 
secondary hosts, deer were inoculated with CWD-infected blood. Several animals 
developed clinical signs, a result consistent with CWD infectivity in blood. 
Also, biochemical strain typing commonly used for rodent models of TSE was 
investigated to assess the importance of genetic variability in natural hosts 
and how to apply these methods to natural hosts. 
Objective 3, Investigate pathogenesis and antemortem detection of bovine 
spongiform encephalopathy (BSE), involves several different research areas. Our 
results in genetic susceptibility of BSE support the now widely accepted 
conclusion that atypical BSE is a spontaneous TSE in cattle. This has important 
implications for the ruminant feed ban, food safety, and our understanding of 
the origins of BSE. Also as part of Obj. 3, we identified the first recognized 
case of genetic BSE where a natural case of BSE was identified in an animal 
containing a polymorphism analogous to a human polymorphism that causes a 
genetic TSE. Bovine spongiform encephalopathy has long been believed to only be 
a feed-borne disease. Together, our results show for the first time the presence 
of three different etiologies for BSE as are known to occur in humans. As part 
of our investigation, classical, and atypical BSE isolates were inoculated into 
cattle. Upon completion, this work will represent the first thorough comparison 
of domestic and international BSE isolates, including both classical and 
atypical BSE. An antemortem diagnostic technique based upon retinal function was 
developed and is routinely applied to experimental animals on site. This 
technique detects a TSE before the onset of clinical signs. Work is ongoing to 
increase the number of animals containing the E211K polymorphism, a potential 
cause of genetic BSE; this will provide the only means by which to prove the 
novel allele may cause BSE. The unusual E211K BSE material has also been 
successfully amplified in one of these animals. 
Objective 4, Develop a method to detect CNS tissue contamination on 
carcasses, resulted in a successful method that may be applied through 
adaptation of existing technology currently used to detect fecal contamination 
on carcasses. 
In Objective 5, Determine effective methods to inactivate TSE agents in 
agricultural settings, compounds applicable to agricultural settings were 
evaluated; the results are being prepared for publication. As part of this 
objective, a natural host model for assessing inactivation was developed. 
Despite experimental success the model is not suitable due to incubation time. 
4.Accomplishments 1. Deer inoculated with domestic isolates of sheep 
scrapie. Scrapie-affected deer exhibit 2 different patterns of disease 
associated prion protein. In some regions of the brain the pattern is much like 
that observed for scrapie, while in others it is more like chronic wasting 
disease (CWD), the transmissible spongiform encephalopathy typically associated 
with deer. This work conducted by ARS scientists at the National Animal Disease 
Center, Ames, IA suggests that an interspecies transmission of sheep scrapie to 
deer may have been the origin of CWD. This is important for husbandry practices 
with both captive deer, elk and sheep for farmers and ranchers attempting to 
keep their herds and flocks free of CWD and scrapie. 
2. Demonstrated transmissibility of K211 BSE, a rare genetic form of bovine 
spongiform encephalopathy (BSE), to cattle. Cattle containing the rare K211 PRNP 
gene have been produced in-house and used in this study conducted by ARS 
scientists at the National Animal Disease Center, Ames, IA. These animals have 
been inoculated with both K211 BSE and classical BSE. The K211 BSE is 
transmissible and progresses far more rapidly in K211 cattle than does classical 
BSE. Because of their genetic susceptibility to BSE, K211 PRNP cattle have a 
very rapid incubation time and may be more susceptible to TSEs, which are two 
characteristics that make them highly desirable for future studies of antemortem 
diagnostics and residual infectivity or risk materials after decontamination. 
The possibility remains that K211 BSE transmitted to conventional cattle will 
result in a disease phenotype similar to classical BSE. If this turns out to be 
true, then it will be very important in that it suggests a very rare genetic 
form of BSE could have been the original source of brain material responsible 
for the U.K. BSE epidemic. Current human and animal feed bans regarding 
specified risk materials from cattle protect humans and animals from a 
recurrence of such an epidemic. 
Review Publications Hamir, A.N., Greenlee, J.J., Stanton, T.B., Smith, 
J.D., Doucette, S., Kunkle, R.A., Stasko, J.A., Richt, J.A., Kehrli, Jr., M.E. 
2011. Experimental inoculation of raccoons (Procyon lotor) with Spiroplasma 
mirum and transmissible mink encephalopathy (TME). Canadian Journal of 
Veterinary Research. 75(1):18–24. 
 Hamir, A.N., Greenlee, J.J., Nicholson, E.M., Kunkle, R.A., Richt, J.A., 
Miller, J.M., Hall, M. 2011. Experimental transmission of chronic wasting 
disease (CWD) from elk and white-tailed deer to fallow deer by intracerebral 
route: final report. Canadian Journal of Veterinary Research. 75(2):152-156. 
Smith, J.D., Hamir, A.N., Greenlee, J.J. 2011. Cartilaginous metaplasia in 
the sclera of Suffolk sheep. Veterinary Pathology. 48(4):827-829. 
Loiacono, C.M., Beckwith, N., Kunkle, R.A., Orcutt, D., Hall, S.M. 2010. 
Detection of PrPSc in formalin-fixed, paraffin embedded tissue by Western blot 
differentiates classical scrapie, Nor98 scrapie, and bovine spongiform 
encephalopathy. Journal of Veterinary Diagnostic Investigation. 22(5):684-689. 
Hamir, A.N., Kehrli, Jr., M.E., Kunkle, R.A., Greenlee, J.J., Nicholson, 
E.M., Richt, J.A., Miller, J.M., Cutlip, R.C. 2011. Experimental interspecies 
transmission studies of the transmissible spongiform encephalopathies to cattle: 
comparison to bovine spongiform encephalopathy in cattle. Journal of Veterinary 
Diagnostic Investigation. 23(3):407-420. 
Nicholson, E.M. 2011. Enrichment of PrPSc in formalin-fixed, 
paraffin-embedded tissues prior to analysis by Western blot. Journal of 
Veterinary Diagnostic Investigation. 23(4):790-792. 
Tuesday, July 17, 2012 
O.I.E. BSE, CWD, SCRAPIE, TSE PRION DISEASE Final Report of the 80th 
General Session, 20 - 25 May 2012 
CHRONIC WASTING DISEASE, CWD, AND THE DEER PENS AT THE FOOT HILLS CAMPUS 
page 30, 
*** Spraker suggested an interesting explanation for the occurrence of CWD. 
The deer pens at the Foot Hills Campus were built some 30-40 years ago by a Dr. 
Bob Davis. At or about that time, allegedly, some scrapie work was conducted at 
this site. When deer were introduced to the pens they occupied ground that had 
previously been occupied by sheep. 
(PLEASE NOTE SOME OF THESE OLD UK GOVERNMENT FILE URLS ARE SLOW TO OPEN, 
AND SOMETIMES YOU MAY HAVE TO CLICK ON MULTIPLE TIMES, PLEASE BE PATIENT, ANY 
PROBLEMS PLEASE WRITE ME PRIVATELY, AND I WILL TRY AND FIX OR SEND YOU OLD PDF 
FILE...TSS) 
IN CONFIDENCE 
PERCEPTIONS OF UNCONVENTIONAL SLOW VIRUS DISEASES OF ANIMALS IN USA 
GAH WELLS 
REPORT OF A VISIT TO THE USA APRIL-MAY 1989 
now, years later, see the latest studies here on scrapie and cwd ; 
PO-039: A comparison of scrapie and chronic wasting disease in white-tailed 
deer 
Justin Greenlee, Jodi Smith, Eric Nicholson US Dept. Agriculture; 
Agricultural Research Service, National Animal Disease Center; Ames, IA USA 
Interspecies transmission studies afford the opportunity to better 
understand the potential host range and origins of prion diseases. The purpose 
of these experiments was to determine susceptibility of white-tailed deer (WTD) 
to scrapie and to compare the resultant clinical signs, lesions, and molecular 
profiles of PrPSc to those of chronic wasting disease (CWD). We inoculated WTD 
intracranially (IC; n = 5) and by a natural route of exposure (concurrent oral 
and intranasal (IN); n = 5) with a US scrapie isolate. All deer were inoculated 
with a 10% (wt/vol) brain homogenate from sheep with scrapie (1ml IC, 1 ml IN, 
30 ml oral). All deer inoculated by the intracranial route had evidence of PrPSc 
accumulation. PrPSc was detected in lymphoid tissues as early as 7 
months-post-inoculation (PI) and a single deer that was necropsied at 15.6 
months had widespread distribution of PrPSc highlighting that PrPSc is widely 
distributed in the CNS and lymphoid tissues prior to the onset of clinical 
signs. IC inoculated deer necropsied after 20 months PI (3/5) had clinical 
signs, spongiform encephalopathy, and widespread distribution of PrPSc in neural 
and lymphoid tissues. The results of this study suggest that there are many 
similarities in the manifestation of CWD and scrapie in WTD after IC inoculation 
including early and widespread presence of PrPSc in lymphoid tissues, clinical 
signs of depression and weight loss progressing to wasting, and an incubation 
time of 21-23 months. Moreover, western blots (WB) done on brain material from 
the obex region have a molecular profile similar to CWD and distinct from 
tissues of the cerebrum or the scrapie inoculum. However, results of microscopic 
and IHC examination indicate that there are differences between the lesions 
expected in CWD and those that occur in deer with scrapie: amyloid plaques were 
not noted in any sections of brain examined from these deer and the pattern of 
immunoreactivity by IHC was diffuse rather than plaque-like. After a natural 
route of exposure, 100% of WTD were susceptible to scrapie. Deer developed 
clinical signs of wasting and mental depression and were necropsied from 28 to 
33 months PI. Tissues from these deer were positive for PrPSc by IHC and WB. 
Similar to IC inoculated deer, samples from these deer exhibited two different 
molecular profiles: samples from obex resembled CWD whereas those from cerebrum 
were similar to the original scrapie inoculum. On further examination by WB 
using a panel of antibodies, the tissues from deer with scrapie exhibit 
properties differing from tissues either from sheep with scrapie or WTD with 
CWD. Samples from WTD with CWD or sheep with scrapie are strongly immunoreactive 
when probed with mAb P4, however, samples from WTD with scrapie are only weakly 
immunoreactive. In contrast, when probed with mAb’s 6H4 or SAF 84, samples from 
sheep with scrapie and WTD with CWD are weakly immunoreactive and samples from 
WTD with scrapie are strongly positive. This work demonstrates that WTD are 
highly susceptible to sheep scrapie, but on first passage, scrapie in WTD is 
differentiable from CWD. 
White-tailed Deer are Susceptible to Scrapie by Natural Route of Infection 
Jodi D. Smith, Justin J. Greenlee, and Robert A. Kunkle; Virus and Prion 
Research Unit, National Animal Disease Center, USDA-ARS 
Interspecies transmission studies afford the opportunity to better 
understand the potential host range and origins of prion diseases. Previous 
experiments demonstrated that white-tailed deer are susceptible to sheep-derived 
scrapie by intracranial inoculation. The purpose of this study was to determine 
susceptibility of white-tailed deer to scrapie after a natural route of 
exposure. Deer (n=5) were inoculated by concurrent oral (30 ml) and intranasal 
(1 ml) instillation of a 10% (wt/vol) brain homogenate derived from a sheep 
clinically affected with scrapie. Non-inoculated deer were maintained as 
negative controls. All deer were observed daily for clinical signs. Deer were 
euthanized and necropsied when neurologic disease was evident, and tissues were 
examined for abnormal prion protein (PrPSc) by immunohistochemistry (IHC) and 
western blot (WB). One animal was euthanized 15 months post-inoculation (MPI) 
due to an injury. At that time, examination of obex and lymphoid tissues by IHC 
was positive, but WB of obex and colliculus were negative. Remaining deer 
developed clinical signs of wasting and mental depression and were necropsied 
from 28 to 33 MPI. Tissues from these deer were positive for scrapie by IHC and 
WB. Tissues with PrPSc immunoreactivity included brain, tonsil, retropharyngeal 
and mesenteric lymph nodes, hemal node, Peyer’s patches, and spleen. This work 
demonstrates for the first time that white-tailed deer are susceptible to sheep 
scrapie by potential natural routes of inoculation. In-depth analysis of tissues 
will be done to determine similarities between scrapie in deer after 
intracranial and oral/intranasal inoculation and chronic wasting disease 
resulting from similar routes of inoculation. 
see full text ; 
Envt.06: 
Zoonotic Potential of CWD: Experimental Transmissions to Non-Human Primates 
Emmanuel Comoy,1,† Valérie Durand,1 Evelyne Correia,1 Aru Balachandran,2 
Jürgen Richt,3 Vincent Beringue,4 Juan-Maria Torres,5 Paul Brown,1 Bob Hills6 
and Jean-Philippe Deslys1 
1Atomic Energy Commission; Fontenay-aux-Roses, France; 2Canadian Food 
Inspection Agency; Ottawa, ON Canada; 3Kansas State University; Manhattan, KS 
USA; 4INRA; Jouy-en-Josas, France; 5INIA; Madrid, Spain; 6Health Canada; Ottawa, 
ON Canada
†Presenting author; Email: emmanuel.comoy@cea.fr 
The constant increase of chronic wasting disease (CWD) incidence in North 
America raises a question about their zoonotic potential. A recent publication 
showed their transmissibility to new-world monkeys, but no transmission to 
old-world monkeys, which are phylogenetically closer to humans, has so far been 
reported. Moreover, several studies have failed to transmit CWD to transgenic 
mice overexpressing human PrP. Bovine spongiform encephalopathy (BSE) is the 
only animal prion disease for which a zoonotic potential has been proven. We 
described the transmission of the atypical BSE-L strain of BSE to cynomolgus 
monkeys, suggesting a weak cattle-to-primate species barrier. We observed the 
same phenomenon with a cattleadapted strain of TME (Transmissible Mink 
Encephalopathy). Since cattle experimentally exposed to CWD strains have also 
developed spongiform encephalopathies, we inoculated brain tissue from 
CWD-infected cattle to three cynomolgus macaques as well as to transgenic mice 
overexpressing bovine or human PrP. Since CWD prion strains are highly 
lymphotropic, suggesting an adaptation of these agents after peripheral 
exposure, a parallel set of four monkeys was inoculated with CWD-infected cervid 
brains using the oral route. Nearly four years post-exposure, monkeys exposed to 
CWD-related prion strains remain asymptomatic. In contrast, bovinized and 
humanized transgenic mice showed signs of infection, suggesting that CWD-related 
prion strains may be capable of crossing the cattle-to-primate species barrier. 
Comparisons with transmission results and incubation periods obtained after 
exposure to other cattle prion strains (c-BSE, BSE-L, BSE-H and cattle-adapted 
TME) will also be presented, in order to evaluate the respective risks of each 
strain. 
Envt.07: 
Pathological Prion Protein (PrPTSE) in Skeletal Muscles of Farmed and Free 
Ranging White-Tailed Deer Infected with Chronic Wasting Disease 
Martin L. Daus,1,† Johanna Breyer,2 Katjs Wagenfuehr,1 Wiebke Wemheuer,2 
Achim Thomzig,1 Walter Schulz-Schaeffer2 and Michael Beekes1 1Robert Koch 
Institut; P24 TSE; Berlin, Germany; 2Department of Neuropathology, Prion and 
Dementia Research Unit, University Medical Center Göttingen; Göttingen, Germany 
†Presenting author; Email: dausm@rki.de 
Chronic wasting disease (CWD) is a contagious, rapidly spreading 
transmissible spongiform encephalopathy (TSE) occurring in cervids in North 
America. Despite efficient horizontal transmission of CWD among cervids natural 
transmission of the disease to other species has not yet been observed. Here, we 
report a direct biochemical demonstration of pathological prion protein PrPTSE 
and of PrPTSE-associated seeding activity in skeletal muscles of CWD-infected 
cervids. The presence of PrPTSE was detected by Western- and postfixed frozen 
tissue blotting, while the seeding activity of PrPTSE was revealed by protein 
misfolding cyclic amplification (PMCA). The concentration of PrPTSE in skeletal 
muscles of CWD-infected WTD was estimated to be approximately 2000- to 
10000-fold lower than in brain tissue. Tissue-blot-analyses revealed that PrPTSE 
was located in muscle- associated nerve fascicles but not, in detectable 
amounts, in myocytes. The presence and seeding activity of PrPTSE in skeletal 
muscle from CWD-infected cervids suggests prevention of such tissue in the human 
diet as a precautionary measure for food safety, pending on further 
clarification of whether CWD may be transmissible to humans. 
Sunday, January 22, 2012 
Chronic Wasting Disease CWD cervids interspecies transmission 
Friday, August 24, 2012 
Diagnostic accuracy of rectal mucosa biopsy testing for chronic wasting 
disease within white-tailed deer (Odocoileus virginianus) herds in North America 
Saturday, September 01, 2012 
Resistance of Soil-Bound Prions to Rumen Digestion 
Monday, September 17, 2012 
Rapid Transepithelial Transport of Prions Following Inhalation 
Thursday, September 27, 2012 
Genetic Depletion of Complement Receptors CD21/35 Prevents Terminal Prion 
Disease in a Mouse Model of Chronic Wasting Disease 
CDC 
October 2012 
Synopsis Occurrence, Transmission, and Zoonotic Potential of Chronic 
Wasting Disease 
Controlling the spread of CWD, especially by human action, is a more 
attainable goal than eradication. Human movement of cervids has likely led to 
spread of CWD in facilities for captive animals, which has most likely 
contributed to establishment of new disease foci in free-ranging populations 
(Figure 1, panel A). Thus, restrictions on human movement of cervids from 
disease-endemic areas or herds continue to be warranted. Anthropogenic factors 
that increase cervid congregation such as baiting and feeding should also be 
restricted to reduce CWD transmission. Appropriate disposal of carcasses of 
animals with suspected CWD is necessary to limit environmental contamination 
(20), and attractive onsite disposal options such as composting and burial 
require further investigation to determine contamination risks. The best options 
for lowering the risk for recurrence in facilities for captive animals with 
outbreaks are complete depopulation, stringent exclusion of free-ranging 
cervids, and disinfection of all exposed surfaces. However, even the most 
extensive decontamination measures may not be sufficient to eliminate the risk 
for disease recurrence (20; S.E. Saunders et al. unpub. data) 
UPDATED CORRESPONDENCE FROM AUTHORS OF THIS STUDY I.E. COLBY, PRUSINER ET 
AL, ABOUT MY CONCERNS OF THE DISCREPANCY BETWEEN THEIR FIGURES AND MY FIGURES OF 
THE STUDIES ON CWD TRANSMISSION TO CATTLE ; 
CWD to cattle figures CORRECTION 
Greetings, 
I believe the statement and quote below is incorrect ; 
"CWD has been transmitted to cattle after intracerebral inoculation, 
although the infection rate was low (4 of 13 animals [Hamir et al. 2001]). This 
finding raised concerns that CWD prions might be transmitted to cattle grazing 
in contaminated pastures." 
Please see ; 
Within 26 months post inoculation, 12 inoculated animals had lost weight, 
revealed abnormal clinical signs, and were euthanatized. Laboratory tests 
revealed the presence of a unique pattern of the disease agent in tissues of 
these animals. These findings demonstrate that when CWD is directly inoculated 
into the brain of cattle, 86% of inoculated cattle develop clinical signs of the 
disease. 
 " although the infection rate was low (4 of 13 animals [Hamir et al. 
2001]). " 
shouldn't this be corrected, 86% is NOT a low rate. ... 
kindest regards, 
Terry S. Singeltary Sr. P.O. Box 42 Bacliff, Texas USA 77518 
Thank you!
Thanks so much for your updates/comments. We intend to publish as rapidly 
as possible all updates/comments that contribute substantially to the topic 
under discussion. 
re-Prions David W. Colby1,* and Stanley B. Prusiner1,2 + Author 
Affiliations
1Institute for Neurodegenerative Diseases, University of California, San 
Francisco, San Francisco, California 94143 2Department of Neurology, University 
of California, San Francisco, San Francisco, California 94143 Correspondence: stanley@ind.ucsf.edu 
Mule deer, white-tailed deer, and elk have been reported to develop CWD. As 
the only prion disease identified in free-ranging animals, CWD appears to be far 
more communicable than other forms of prion disease. CWD was first described in 
1967 and was reported to be a spongiform encephalopathy in 1978 on the basis of 
histopathology of the brain. Originally detected in the American West, CWD has 
spread across much of North America and has been reported also in South Korea. 
In captive populations, up to 90% of mule deer have been reported to be positive 
for prions (Williams and Young 1980). The incidence of CWD in cervids living in 
the wild has been estimated to be as high as 15% (Miller et al. 2000). The 
development of transgenic (Tg) mice expressing cervid PrP, and thus susceptible 
to CWD, has enhanced detection of CWD and the estimation of prion titers 
(Browning et al. 2004; Tamgüney et al. 2006). Shedding of prions in the feces, 
even in presymptomatic deer, has been identified as a likely source of infection 
for these grazing animals (Williams and Miller 2002; Tamgüney et al. 2009b). CWD 
has been transmitted to cattle after intracerebral inoculation, although the 
infection rate was low (4 of 13 animals [Hamir et al. 2001]). This finding 
raised concerns that CWD prions might be transmitted to cattle grazing in 
contaminated pastures. 
snip... 
----- Original Message ----- 
From: David Colby To: flounder9@verizon.net 
Cc: stanley@XXXXXXXX 
Sent: Tuesday, March 01, 2011 8:25 AM 
Subject: Re: FW: re-Prions David W. Colby1,* and Stanley B. Prusiner1,2 + 
Author Affiliations 
Dear Terry Singeltary, 
Thank you for your correspondence regarding the review article Stanley 
Prusiner and I recently wrote for Cold Spring Harbor Perspectives. Dr. Prusiner 
asked that I reply to your message due to his busy schedule. We agree that the 
transmission of CWD prions to beef livestock would be a troubling development 
and assessing that risk is important. In our article, we cite a peer-reviewed 
publication reporting confirmed cases of laboratory transmission based on 
stringent criteria. The less stringent criteria for transmission described in 
the abstract you refer to lead to the discrepancy between your numbers and ours 
and thus the interpretation of the transmission rate. We stand by our assessment 
of the literature--namely that the transmission rate of CWD to bovines appears 
relatively low, but we recognize that even a low transmission rate could have 
important implications for public health and we thank you for bringing attention 
to this matter. Warm Regards, David Colby -- David Colby, PhDAssistant Professor 
Department of Chemical Engineering University of Delaware 
===========END...TSS============== 
SNIP...SEE FULL TEXT ; 
UPDATED DATA ON 2ND CWD STRAIN Wednesday, September 08, 2010 CWD PRION 
CONGRESS SEPTEMBER 8-11 2010 
Sunday, August 19, 2012 
Susceptibility of cattle to the agent of chronic wasting disease from elk 
after intracranial inoculation 2012 
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES Location: Virus and Prion Research 
Unit 
PO-081: Chronic wasting disease in the cat— Similarities to feline 
spongiform encephalopathy (FSE) 
PO-081: Chronic wasting disease in the cat— Similarities to feline 
spongiform encephalopathy (FSE) 
Thursday, May 31, 2012 
CHRONIC WASTING DISEASE CWD PRION2012 Aerosol, Inhalation transmission, 
Scrapie, cats, species barrier, burial, and more 
PLUS, THE CDC DID NOT PUT THIS WARNING OUT FOR THE WELL BEING OF THE DEER 
AND ELK ; 
Thursday, May 26, 2011 
Travel History, Hunting, and Venison Consumption Related to Prion Disease 
Exposure, 2006-2007 FoodNet Population Survey 
Journal of the American Dietetic Association Volume 111, Issue 6 , Pages 
858-863, June 2011. 
NOR IS THE FDA recalling this CWD positive elk meat for the well being of 
the dead elk ; 
Wednesday, March 18, 2009 
Noah's Ark Holding, LLC, Dawson, MN RECALL Elk products contain meat 
derived from an elk confirmed to have CWD NV, CA, TX, CO, NY, UT, FL, OK RECALLS 
AND FIELD CORRECTIONS: FOODS CLASS II 
now, let’s see what the authors said about this casual link, personal 
communications years ago. see where it is stated NO STRONG evidence. so, does 
this mean there IS casual evidence ???? 
“Our conclusion stating that we found no strong evidence of CWD 
transmission to humans” 
From: TSS (216-119-163-189.ipset45.wt.net) 
Subject: CWD aka MAD DEER/ELK TO HUMANS ??? 
Date: September 30, 2002 at 7:06 am PST 
From: "Belay, Ermias" 
To: 
Cc: "Race, Richard (NIH)" ; ; "Belay, Ermias" 
Sent: Monday, September 30, 2002 9:22 AM 
Subject: RE: TO CDC AND NIH - PUB MED- 3 MORE DEATHS - CWD - YOUNG HUNTERS 
Dear Sir/Madam, 
In the Archives of Neurology you quoted (the abstract of which was attached 
to your email), we did not say CWD in humans will present like variant CJD. 
That assumption would be wrong. I encourage you to read the whole article 
and call me if you have questions or need more clarification (phone: 
404-639-3091). Also, we do not claim that "no-one has ever been infected with 
prion disease from eating venison." Our conclusion stating that we found no 
strong evidence of CWD transmission to humans in the article you quoted or in 
any other forum is limited to the patients we investigated. 
Ermias Belay, M.D. Centers for Disease Control and Prevention 
-----Original Message----- 
From: 
Sent: Sunday, September 29, 2002 10:15 AM 
To: rr26k@nih.gov; rrace@niaid.nih.gov; ebb8@CDC.GOV 
Subject: TO CDC AND NIH - PUB MED- 3 MORE DEATHS - CWD - YOUNG HUNTERS 
Sunday, November 10, 2002 6:26 PM ......snip........end..............TSS 
Thursday, April 03, 2008 
A prion disease of cervids: Chronic wasting disease 
2008 1: Vet Res. 2008 Apr 3;39(4):41 
A prion disease of cervids: Chronic wasting disease 
Sigurdson CJ. 
snip... 
*** twenty-seven CJD patients who regularly consumed venison were reported 
to the Surveillance Center***, 
snip... 
full text ; 
CWD ongoing experiment on humans, long term $$$ 
Monday, November 14, 2011 
WYOMING Creutzfeldt Jakob Disease, CWD, TSE, PRION REPORTING 2011 
Wednesday, November 16, 2011 
Wisconsin Creutzfeldt Jakob Disease, CWD, TSE, PRION REPORTING 2011 
Sunday, November 13, 2011 
COLORADO CWD CJD TSE PRION REPORTING 2011 
Thursday, March 29, 2012 
atypical Nor-98 Scrapie has spread from coast to coast in the USA 2012 
NIAA Annual Conference April 11-14, 2011San Antonio, Texas 
Monday, November 30, 2009 
USDA AND OIE COLLABORATE TO EXCLUDE ATYPICAL SCRAPIE NOR-98 ANIMAL HEALTH 
CODE 
Wednesday, February 16, 2011
IN CONFIDENCE SCRAPIE TRANSMISSION TO CHIMPANZEES 
IN CONFIDENCE
reference...
RB3.20
TRANSMISSION TO CHIMPANZEES
1. Kuru and CJD have been successfully transmitted to chimpanzees but 
scrapie and TME have not.
2. We cannot say that scrapie will not transmit to chimpanzees. There are 
several scrapie strains and I am not aware that all have been tried (that would 
have to be from mouse passaged material). Nor has a wide enough range of field 
isolates subsequently strain typed in mice been inoculated by the appropriate 
routes (i/c, ilp and i/v) :
3. I believe the proposed experiment to determine transmissibility, if 
conducted, would only show the susceptibility or resistance of the chimpanzee to 
infection/disease by the routes used and the result could not be interpreted for 
the predictability of the susceptibility for man. Proposals for prolonged oral 
exposure of chimpanzees to milk from cattle were suggested a long while ago and 
rejected.
4. In view of Dr Gibbs' probable use of chimpazees Mr Wells' comments 
(enclosed) are pertinent. I have yet to receive a direct communication from Dr 
Schellekers but before any collaboration or provision of material we should 
identify the Gibbs' proposals and objectives.
5. A positive result from a chimpanzee challenged severely would likely 
create alarm in some circles even if the result could not be interpreted for 
man. I have a view that all these agents could be transmitted provided a large 
enough dose by appropriate routes was given and the animals kept long enough. 
Until the mechanisms of the species barrier are more clearly understood it might 
be best to retain that hypothesis.
6. A negative result would take a lifetime to determine but that would be a 
shorter period than might be available for human exposure and it would still not 
answer the question regarding mans' susceptibility. In the meantime no doubt the 
negativity would be used defensively. It would however be counterproductive if 
the experiment finally became positive. We may learn more about public reactions 
following next Monday' s meeting.
R. Bradley
23 September 1990
CVO (+Mr Wells' comments)
Dr T W A Little
Dr B J Shreeve
90/9.23/1.1.
see full text ; 
Thursday, March 29, 2012 
atypical Nor-98 Scrapie has spread from coast to coast in the USA 2012 
NIAA Annual Conference April 11-14, 2011San Antonio, Texas 
Monday, November 30, 2009 
USDA AND OIE COLLABORATE TO EXCLUDE ATYPICAL SCRAPIE NOR-98 ANIMAL HEALTH 
CODE 
Thursday, August 12, 2010
Seven main threats for the future linked to prions
First threat 
The TSE road map defining the evolution of European policy for protection 
against prion diseases is based on a certain numbers of hypotheses some of which 
may turn out to be erroneous. In particular, a form of BSE (called atypical 
Bovine Spongiform Encephalopathy), recently identified by systematic testing in 
aged cattle without clinical signs, may be the origin of classical BSE and thus 
potentially constitute a reservoir, which may be impossible to eradicate if a 
sporadic origin is confirmed. ***Also, a link is suspected between atypical BSE 
and some apparently sporadic cases of Creutzfeldt-Jakob disease in humans. These 
atypical BSE cases constitute an unforeseen first threat that could sharply 
modify the European approach to prion diseases. 
Second threat 
snip... 
EFSA Journal 2011 The European Response to BSE: A Success Story 
This is an interesting editorial about the Mad Cow Disease debacle, and 
it's ramifications that will continue to play out for decades to come ; 
Monday, October 10, 2011 
EFSA Journal 2011 The European Response to BSE: A Success Story 
snip... 
EFSA and the European Centre for Disease Prevention and Control (ECDC) 
recently delivered a scientific opinion on any possible epidemiological or 
molecular association between TSEs in animals and humans (EFSA Panel on 
Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical 
BSE prions as the only TSE agents demonstrated to be zoonotic so far but the 
possibility that a small proportion of human cases so far classified as 
"sporadic" CJD are of zoonotic origin could not be excluded. Moreover, 
transmission experiments to non-human primates suggest that some TSE agents in 
addition to Classical BSE prions in cattle (namely L-type Atypical BSE, 
Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic 
wasting disease (CWD) agents) might have zoonotic potential. 
snip... 
see follow-up here about North America BSE Mad Cow TSE prion risk factors, 
and the ever emerging strains of Transmissible Spongiform Encephalopathy in many 
species here in the USA, including humans ; 
2011 Monday, September 26, 2011 
L-BSE BASE prion and atypical sporadic CJD 
Saturday, March 5, 2011 
MAD COW ATYPICAL CJD PRION TSE CASES WITH CLASSIFICATIONS PENDING ON THE 
RISE IN NORTH AMERICA 
Wednesday, August 01, 2012 
Behavioural and Psychiatric Features of the Human Prion Diseases: 
Experience in 368 Prospectively Studied Patients
Monday, August 06, 2012 
Atypical neuropathological sCJD-MM phenotype with abundant white matter 
Kuru-type plaques sparing the cerebellar cortex 
Tuesday, June 26, 2012 
Creutzfeldt Jakob Disease Human TSE report update North America, Canada, 
Mexico, and USDA PRION UNIT as of May 18, 2012 
type determination pending Creutzfeldt Jakob Disease (tdpCJD), is on the 
rise in Canada and the USA
Friday, August 24, 2012 
Iatrogenic prion diseases in humans: an update 
Monday, July 23, 2012
The National Prion Disease Pathology Surveillance Center July 2012 
2011 Monday, September 26, 2011 
L-BSE BASE prion and atypical sporadic CJD 
Saturday, March 5, 2011 
MAD COW ATYPICAL CJD PRION TSE CASES WITH CLASSIFICATIONS PENDING ON THE 
RISE IN NORTH AMERICA 
Wednesday, August 01, 2012 
Behavioural and Psychiatric Features of the Human Prion Diseases: 
Experience in 368 Prospectively Studied Patients
Monday, August 06, 2012 
Atypical neuropathological sCJD-MM phenotype with abundant white matter 
Kuru-type plaques sparing the cerebellar cortex 
Tuesday, June 26, 2012 
Creutzfeldt Jakob Disease Human TSE report update North America, Canada, 
Mexico, and USDA PRION UNIT as of May 18, 2012 
type determination pending Creutzfeldt Jakob Disease (tdpCJD), is on the 
rise in Canada and the USA
Friday, August 24, 2012 
Iatrogenic prion diseases in humans: an update 
Terry S. Singeltary Sr. on the Creutzfeldt-Jakob Disease Public Health 
Crisis 
full text with source references ; 
re-Human Prion Diseases in the United States Posted by flounder on 01 Jan 
2010 at 18:11 GMT I kindly disagree with your synopsis for the following reasons 
; 
Tuesday, November 08, 2011 
Can Mortality Data Provide Reliable Indicators for Creutzfeldt-Jakob 
Disease Surveillance? A Study in France from 2000 to 2008 Vol. 37, No. 3-4, 2011 
Original Paper
Conclusions:These findings raise doubt about the possibility of a reliable 
CJD surveillance only based on mortality data. 
Views & Reviews
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in 
the United States
Ermias D. Belay, MD, Ryan A. Maddox, MPH, Pierluigi Gambetti, MD and 
Lawrence B. Schonberger, MD
+ Author Affiliations
From the Division of Viral and Rickettsial Diseases (Drs. Belay and 
Schonberger and R.A. Maddox), National Center for Infectious Diseases, Centers 
for Disease Control and Prevention, Atlanta, GA; and National Prion Disease 
Pathology Surveillance Center (Dr. Gambetti), Division of Neuropathology, 
Institute of Pathology, Case Western Reserve University, Cleveland, OH.
Address correspondence and reprint requests to Dr. Ermias D. Belay, 1600 
Clifton Road, Mailstop A-39, Atlanta, GA 30333. 
26 March 2003
Terry S. Singeltary, retired (medically) CJD WATCH
I lost my mother to hvCJD (Heidenhain Variant CJD). I would like to comment 
on the CDC's attempts to monitor the occurrence of emerging forms of CJD. 
Asante, Collinge et al [1] have reported that BSE transmission to the 
129-methionine genotype can lead to an alternate phenotype that is 
indistinguishable from type 2 PrPSc, the commonest sporadic CJD. However, CJD 
and all human TSEs are not reportable nationally. CJD and all human TSEs must be 
made reportable in every state and internationally. I hope that the CDC does not 
continue to expect us to still believe that the 85%+ of all CJD cases which are 
sporadic are all spontaneous, without route/source. We have many TSEs in the USA 
in both animal and man. CWD in deer/elk is spreading rapidly and CWD does 
transmit to mink, ferret, cattle, and squirrel monkey by intracerebral 
inoculation. With the known incubation periods in other TSEs, oral transmission 
studies of CWD may take much longer. Every victim/family of CJD/TSEs should be 
asked about route and source of this agent. To prolong this will only spread the 
agent and needlessly expose others. In light of the findings of Asante and 
Collinge et al, there should be drastic measures to safeguard the medical and 
surgical arena from sporadic CJDs and all human TSEs. I only ponder how many 
sporadic CJDs in the USA are type 2 PrPSc? 
Diagnosis and Reporting of Creutzfeldt-Jakob Disease Singeltary, Sr et al. 
JAMA.2001; 285: 733-734. Vol. 285 No. 6, February 14, 2001 JAMA
Diagnosis and Reporting of Creutzfeldt-Jakob Disease
To the Editor: In their Research Letter, Dr Gibbons and colleagues1 
reported that the annual US death rate due to Creutzfeldt-Jakob disease (CJD) 
has been stable since 1985. These estimates, however, are based only on reported 
cases, and do not include misdiagnosed or preclinical cases. It seems to me that 
misdiagnosis alone would drastically change these figures. An unknown number of 
persons with a diagnosis of Alzheimer disease in fact may have CJD, although 
only a small number of these patients receive the postmortem examination 
necessary to make this diagnosis. Furthermore, only a few states have made CJD 
reportable. Human and animal transmissible spongiform encephalopathies should be 
reportable nationwide and internationally.
Terry S. Singeltary, Sr Bacliff, Tex
1. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob 
disease in the United States: 1979-1998. JAMA. 2000;284:2322-2323. FREE FULL 
TEXT 
2 January 2000
British Medical Journal
U.S. Scientist should be concerned with a CJD epidemic in the U.S., as 
well
15 November 1999
British Medical Journal
vCJD in the USA * BSE in U.S. 
Saturday, January 2, 2010
Human Prion Diseases in the United States January 1, 2010 ***FINAL*** 
14th ICID International Scientific Exchange Brochure -
Final Abstract Number: ISE.114
Session: International Scientific Exchange
Transmissible Spongiform encephalopathy (TSE) animal and human TSE in North 
America update October 2009
T. Singeltary
Bacliff, TX, USA
Background:
An update on atypical BSE and other TSE in North America. Please remember, 
the typical U.K. c-BSE, the atypical l-BSE (BASE), and h-BSE have all been 
documented in North America, along with the typical scrapie's, and atypical 
Nor-98 Scrapie, and to date, 2 different strains of CWD, and also TME. All these 
TSE in different species have been rendered and fed to food producing animals 
for humans and animals in North America (TSE in cats and dogs ?), and that the 
trading of these TSEs via animals and products via the USA and Canada has been 
immense over the years, decades.
Methods:
12 years independent research of available data
Results:
I propose that the current diagnostic criteria for human TSEs only enhances 
and helps the spreading of human TSE from the continued belief of the UKBSEnvCJD 
only theory in 2009. With all the science to date refuting it, to continue to 
validate this old myth, will only spread this TSE agent through a multitude of 
potential routes and sources i.e. consumption, medical i.e., surgical, blood, 
dental, endoscopy, optical, nutritional supplements, cosmetics etc.
Conclusion:
I would like to submit a review of past CJD surveillance in the USA, and 
the urgent need to make all human TSE in the USA a reportable disease, in every 
state, of every age group, and to make this mandatory immediately without 
further delay. The ramifications of not doing so will only allow this agent to 
spread further in the medical, dental, surgical arena's. Restricting the 
reporting of CJD and or any human TSE is NOT scientific. Iatrogenic CJD knows NO 
age group, TSE knows no boundaries. I propose as with Aguzzi, Asante, Collinge, 
Caughey, Deslys, Dormont, Gibbs, Gajdusek, Ironside, Manuelidis, Marsh, et al 
and many more, that the world of TSE Transmissible Spongiform Encephalopathy is 
far from an exact science, but there is enough proven science to date that this 
myth should be put to rest once and for all, and that we move forward with a new 
classification for human and animal TSE that would properly identify the 
infected species, the source species, and then the route. 
re-Human Prion Diseases in the United States Posted by flounder on 01 Jan 
2010 at 18:11 GMT I kindly disagree with your synopsis for the following reasons 
; 
Wednesday, May 16, 2012 
Alzheimer’s disease and Transmissible Spongiform Encephalopathy prion 
disease, Iatrogenic, what if ? 
Proposal ID: 29403 
Monday, August 20, 2012 
CASE REPORTS CREUTZFELDT-JAKOB DISEASE: AN UNDER-RECOGNIZED CAUSE OF 
DEMENTIA 
Friday, October 05, 2012 
Differential Diagnosis of Jakob-Creutzfeldt Disease 
see the Duke, Pa, Yale, and Mexican study here, showing the misdiagnosis of 
CJD TSE prion disease as Alzheimers ; 
Monday, July 23, 2012
The National Prion Disease Pathology Surveillance Center July 2012 
 TSS 

